Nuclear Medicine Imaging Tools in Fever of Unknown Origin (FUO): Time for a Revisit and Appropriate Use Criteria

William F Wright,Sheetal Kandiah,Rebecca Brady,Barry L Shulkin,Christopher J Palestro,Sanjay K Jain

DOI: https://doi.org/10.1093/cid/ciae115

IF: 20.999

2024-03-06

Clinical Infectious Diseases

Abstract:Fever of unknown origin (FUO) is a clinical conundrum for patients and clinicians alike and imaging studies are often performed as part of the diagnostic workup of these patients. Recently, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) convened and approved a guideline on the use of nuclear medicine tools for FUO. The guidelines support the use of 2-18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) in adults and children with FUO. 18F-FDG PET/CT allows the detection and localization of foci of hypermetabolic lesions with high sensitivity, based on 18F-FDG uptake in glycolytically active cells that may represent inflammation, infection, or neoplasia. Clinicians should consider and insurers should cover 18F-FDG PET/CT when evaluating patients with FUO, particularly when other clinical clues and preliminary studies are unrevealing.

immunology,infectious diseases,microbiology

What problem does this paper attempt to address?

The paper primarily explores the diagnostic challenges of Fever of Unknown Origin (FUO) and emphasizes the application value of positron emission tomography combined with 18F-fluorodeoxyglucose (18F-FDG PET/CT) in the diagnosis of FUO. Specifically, the paper attempts to address the following issues:

1. **Definition and Diagnostic Criteria of FUO**: The definition and diagnostic criteria of FUO vary across different literature, and the lack of a unified standard complicates clinical diagnosis. The paper reviews the historical definitions of FUO and discusses the impact of different age groups, geographical locations, and disease classifications on FUO diagnosis.

2. **Limitations of Traditional Diagnostic Methods**: Traditional laboratory tests and imaging techniques (such as ultrasound, CT, etc.) have low sensitivity in diagnosing FUO and cannot effectively identify the cause. These methods often need to be combined with other clues to reach a diagnostic conclusion.

3. **Application of 18F-FDG PET/CT**: The paper highlights the advantages of 18F-FDG PET/CT in the diagnosis of FUO, especially when used early, as it can improve the diagnostic rate and reduce unnecessary tests and hospitalization time. Multiple studies have shown that 18F-FDG PET/CT has high diagnostic sensitivity in FUO patients and helps in the early detection of inflammation, infection, or tumor lesions.

4. **Appropriate Use Criteria**: The paper introduces the Appropriate Use Criteria (AUC) for the use of nuclear medicine imaging tools in FUO patients, published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and recommends the early use of 18F-FDG PET/CT in FUO diagnosis.

In summary, the paper aims to promote the standardization of the FUO diagnostic process and emphasizes the importance and practicality of 18F-FDG PET/CT in FUO diagnosis.